Novartis could stick with 77 percent stake in Alcon

Swiss drugmaker Novartis AG has not ruled out sticking with its 77 percent stake in US-listed eyecare group Alcon, Novartis chief executive Joe Jimenez was quoted as saying on Tuesday. "The intention is to have 100 per cent. But Nestle owned 77 per c...

Full Story →